Evidence map›Paper›PMID 40952454›Full record

ArticlePathologie (Heidelberg, Germany)2025

[Vascular neoplasms of the liver].

Felix Keil, Thomas Metzler, Stefan Thomann, Thomas Albrecht, Carolin Mogler

Abstract readEnglish Abstract
In one paragraph

Article in Pathologie (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Felix KeilInstitut für Pathologie, Universität Regensburg, Regensburg, Deutschland.
Thomas MetzlerInstitut für Allgemeine Pathologie und Pathologische Anatomie, School of Medicine and Health, Technische Universität München, Trogerstraße 18, 81675, München, Deutschland.
Stefan ThomannInstitut für Systemimmunologie, Julius-Maximilians-Universität Würzburg, Würzburg, Deutschland.
Thomas AlbrechtInstitut für Pathologie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
Carolin MoglerInstitut für Allgemeine Pathologie und Pathologische Anatomie, School of Medicine and Health, Technische Universität München, Trogerstraße 18, 81675, München, Deutschland. Carolin.Mogler@tum.de.ORCID http://orcid.org/0000-0003-3400-7254

Funding

DeutscheForschungsgemeinschaft 39404578
6 · The paper itself

Abstract

Vascular neoplasms of the liver encompass a spectrum ranging from the common benign hemangiomas to the very rare malignant vascular neoplasms, namely epithelioid hemangioendotheliomas (EHE) and angiosarcomas. Despite their high prevalence, hemangiomas are rarely biopsied or resected-typically only in cases with atypical imaging features or when large size raises concern for rupture. In this overview, we place particular emphasis on the newly described entity known as hepatic small vessel neoplasm (HSVN). Epithelioid hemangioendotheliomas and angiosarcomas, due to their rarity and several diagnostic pitfalls, can pose significant diagnostic challenges in histopathology. These pitfalls will be specifically addressed here.

Indexed as

HemangiosarcomaLiver NeoplasmsVascular NeoplasmsDiagnosis, DifferentialHemangioendothelioma, EpithelioidHemangiomaHumansLiverAngiosarcomaEpitheloid hemangioendotheliomaHemangiomaHSVNImmunohistochemistry

Identifiers

PMID40952454
PMCPMC12552387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.